The market expects BioHarvest Sciences Inc. (BHST) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to ...

The market expects Gambling.com Group Limited (GAMB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 15, 2025, might help the stock move higher if these key ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Cava Group (CAVA) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 15. On the ...

Knightscope, Inc. (KSCP) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stoc ...

Company Overview - Flexible Solutions International Inc. (FSI) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.05, reflecting a +25% change, and revenues anticipated at $10.2 million, up 10.5% from the previous year [3]. Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for FSI matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - FSI currently holds a Zacks Rank of 4 (Sell), complicating the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, FSI met the consensus EPS estimate of $0.05, resulting in no surprise [12]. - Over the past four quarters, FSI has only surpassed consensus EPS estimates once [13]. Industry Comparison - In the Zacks Chemical - Specialty industry, Hawkins (HWKN) is expected to post earnings of $0.74 per share, indicating a +12.1% year-over-year change, with revenues projected at $230.08 million, up 3.2% from the previous year [17].

For the quarter ended March 2025, SharkNinja, Inc. (SN) reported revenue of $1.22 billion, up 14.7% over the same period last year. EPS came in at $0.87, compared to $1.06 in the year-ago quarter.The reported revenue represents a surprise of +3.99% over the Zacks Consensus Estimate of $1.18 billion. With the consensus EPS estimate being $0.73, the EPS surprise was +19.18%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street e ...

Vishay Intertechnology, Inc. (VSH) reported a first-quarter 2025 loss of 3 cents per share, meeting the Zacks Consensus Estimate. However, this compares unfavorably with the year-ago quarter’s earnings of 22 cents.Vishay Intertechnology’s revenues of $715.2 million beat the Zacks Consensus Estimate by 0.74%. However, the top line declined 4.2% on a year-over-year basis.The company’s weak first-quarter performance weighed on investor sentiments, leading to a fall of 9.8% in its share price on Wednesday. Year ...

For the quarter ended March 2025, Nutrien (NTR) reported revenue of $5.1 billion, down 5.4% over the same period last year. EPS came in at $0.11, compared to $0.46 in the year-ago quarter.The reported revenue represents a surprise of -4.18% over the Zacks Consensus Estimate of $5.32 billion. With the consensus EPS estimate being $0.33, the EPS surprise was -66.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectati ...

Core Insights - Phibro Animal Health (PAHC) reported a revenue of $347.8 million for the quarter ended March 2025, marking a year-over-year increase of 32.1% and an EPS of $0.63 compared to $0.31 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $350.54 million by 0.78%, while the EPS exceeded the consensus estimate of $0.52 by 21.15% [1] Financial Performance - The company’s net sales by region showed varied performance: - United States: $209.94 million, a 31.8% increase year-over-year, but below the estimated $221.68 million [4] - Asia Pacific: $28.22 million, a significant 65.2% increase year-over-year, exceeding the estimate of $23.44 million [4] - Europe, Middle East and Africa: $38.91 million, a 17.3% increase year-over-year, below the estimate of $48.03 million [4] - Latin America and Canada: $70.75 million, a 31.9% increase year-over-year, surpassing the estimate of $55.39 million [4] Segment Performance - Animal Health segment reported net sales of $258.40 million, a 42.5% increase year-over-year, but below the estimate of $265.65 million [4] - Mineral Nutrition segment reported net sales of $66.80 million, a 4% increase year-over-year, slightly below the estimate of $66.88 million [4] - Animal Health Vaccines reported net sales of $33.40 million, a 1.5% increase year-over-year, below the estimate of $38.78 million [4] - Animal Health MFAs and other reported net sales of $181.60 million, a substantial 67.8% increase year-over-year, exceeding the estimate of $155.57 million [4] - Performance Products reported net sales of $22.70 million, a 28.5% increase year-over-year, surpassing the estimate of $18.01 million [4] EBITDA Performance - Adjusted EBITDA for the Animal Health segment was $63.10 million, above the average estimate of $60.59 million [4] - Adjusted EBITDA for the Corporate segment was -$17.30 million, better than the estimated -$19.57 million [4] Stock Performance - Phibro's shares have returned +6.5% over the past month, compared to the Zacks S&P 500 composite's +10.6% change, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]

For the quarter ended March 2025, Compass Minerals (CMP) reported revenue of $494.6 million, up 35.9% over the same period last year. EPS came in at $0.63, compared to $1.49 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $413.88 million, representing a surprise of +19.50%. The company delivered an EPS surprise of +61.54%, with the consensus EPS estimate being $0.39.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...